Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. 1990

C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
Cattedra Malattie Infettive, Università di Parma, Italy.

The proliferative response of PBMC to hepatitis B virus (HBV) envelope, core, and e Ag was analyzed prospectively in 21 patients with acute self-limited HBV infection and compared with the response of patients with chronic HBV infection and different levels of HBV replication (i.e., hepatitis e Ag (HBeAg)- or anti-HBe-positive) and liver damage (i.e., chronic active hepatitis or chronic asymptomatic carriers). Our results indicate that: 1) HBV-infected subjects who develop a self-limited acute hepatitis show a vigorous PBMC response to hepatitis B core Ag and HBeAg, as expression of T cell activation; 2) appearance of a detectable lymphocyte response to HBV nucleocapsid Ag is temporally associated with the clearance of HBV envelope Ag; 3) in patients with chronic HBV infection the level of T cell responsiveness to hepatitis B core Ag and to HBeAg is significantly lower than that observed during acute infection; 4) T cell sensitization to HBV envelope Ag in acute and chronic HBV infection is usually undetectable and when measurable is expressed transiently and at low levels. These results may reflect immune events of pathogenetic relevance with respect to evolution of disease and viral clearance.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic

Related Publications

C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
January 1990, Springer seminars in immunopathology,
C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
September 2014, Microbial pathogenesis,
C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
January 2023, Journal of inflammation research,
C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
January 1995, Springer seminars in immunopathology,
C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
May 1999, Journal of medical virology,
C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
February 1991, Liver,
C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
October 2007, Hepatology research : the official journal of the Japan Society of Hepatology,
C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
July 2015, Cold Spring Harbor perspectives in medicine,
C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
December 2016, Expert opinion on biological therapy,
C Ferrari, and A Penna, and A Bertoletti, and A Valli, and A D Antoni, and T Giuberti, and A Cavalli, and M A Petit, and F Fiaccadori
January 1980, Voprosy virusologii,
Copied contents to your clipboard!